Evidence map›Paper›PMID 36936971›Full record

ArticleFrontiers in immunology2023

Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma.

Fukai Wen, Fanshuai Meng, Xuewen Li, Qingyu Li, Jiaming Liu, Rui Zhang, Yunzheng Zhao, Yu Zhang, Xin Wang, Shuai Ju and 2 more

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Endocytosis in cancer and cancer therapy.Nature reviews. Cancer · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Fukai WenDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Fanshuai MengDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Xuewen LiThe Department of Inpatient Central Operating Room, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Qingyu LiDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Jiaming LiuDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Rui ZhangDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yunzheng ZhaoDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yu ZhangDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Xin WangDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Shuai JuDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yifeng CuiDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhaoyang LuDepartment of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Harbin Medical University · CNFirst Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The protein-coding gene Methods: A database-based pan-cancer expression analysis of RAB22A was performed. Kaplan-Meier analysis and Cox regression were performed to evaluate the association between Results: Conclusions: RAB22A is a potential therapeutic target for improving HCC prognosis and is closely related to immune cell infiltration.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsAdenosineHumansPhosphorylationPrognosisProtein Processing, Post-Translationalrab GTP-Binding ProteinsAdenosineRAB22A protein, humanrab GTP-Binding Proteinsbioinformatics analysisbiomarkercancer immune infiltrateshepatocellular carcinomaprognosisRAB22A

Identifiers

PMID36936971
PMCPMC10021109
OpenAlexW4323042285

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read89
table measurements read2
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.